Cargando…
Observational Study of Once-Daily Insulin Detemir in People with Type 2 Diabetes Aged 75 Years or Older: A Sub-Analysis of Data from the Study of Once-Daily Levemir (SOLVE)
OBJECTIVES: Older patients are particularly vulnerable to hypoglycaemia. The aim of this study was to evaluate the response to initiation of once-daily insulin detemir in patients aged ≥75 years with type 2 diabetes mellitus (T2DM) treated with one or more oral antidiabetic drugs (OADs). METHODS: A...
Autores principales: | Karnieli, Eddy, Baeres, Florian M. M., Dzida, Grzegorz, Ji, Qiuhe, Ligthelm, Robert, Ross, Stuart, Svendsen, Anne Louise, Yale, Jean-François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing AG
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574560/ https://www.ncbi.nlm.nih.gov/pubmed/23371395 http://dx.doi.org/10.1007/s40266-013-0054-3 |
Ejemplares similares
-
Initiation of once daily insulin detemir is not associated with weight gain in patients with type 2 diabetes mellitus: results from an observational study
por: Yale, Jean-François, et al.
Publicado: (2013) -
Detemir as a once-daily basal insulin in type 2 diabetes
por: Nelson, Scott E
Publicado: (2011) -
Once-daily dosing of gentamicin.
por: Soper, D E
Publicado: (1998) -
ONCE DAILY RISPERIDONE IN TREATMENT OF SCHIZOPHRENIA
por: Agarwal, Vivek, et al.
Publicado: (2001) -
Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification
por: Toyos, Melissa M.
Publicado: (2019)